ROBLEDA PELT: Open Payments
NPI 1497190383 · WESLEY CHAPEL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 22 payments from 11 companies in 2025. Trend: 2023 $358 · 2024 $2,069 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Avadel CNS Pharmaceuticals, LLC | 4 | $122 |
| Regeneron Healthcare Solutions, Inc. | 2 | $68 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $63 |
| Optinose US, Inc. | 3 | $62 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Inspire Medical Systems, Inc. | 1 | $59 |
| GENZYME CORPORATION | 2 | $44 |
| JAZZ PHARMACEUTICALS INC. | 1 | $27 |
| ABBVIE INC. | 1 | $22 |
| Lilly USA, LLC | 1 | $16 |
Products named: LUMRYZ, DUPIXENT, NEFFY, Xhance, NUCALA, INSPIRE, XYWAV, ZEPBOUND.
Industry payments across FL — which companies pay providers there.
